Dr. Reddy's Laboratories Ltd Common Stock vs Trane Technologies plc — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while Trane Technologies plc trades at $471.85 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 9.8× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Trane Technologies plc pays the higher dividend (0.88%). Which is the better fit depends on your goals.
| RDY | TT | |
|---|---|---|
Market Cap | $10.78B | $105.17B |
Volume | 2,724,343 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $15.38 | $503.46 |
52-Week Low | $11.38 | $376.43 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $10.68B | $108.47B |
Dividend Yield | 0.65% | 0.88% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →